Join our Virtual Grand Rounds: COVID-19 and the Holidays - Where Do We Stand? Updates on Testing and Outpatient Treatment on Tuesday, December 7, 2021, from 12:00 p.m. PT to 1:30 p.m. PT
As we navigate this year’s holiday season, the choices before us feel very different than those in 2020. More people are traveling and choosing to gather with family and friends to celebrate, and still, many of us are moving forward with trepidation. As we make our own decisions and counsel our patients about whether to travel and gather, it is essential to have a full understanding of the local COVID-19 conditions including vaccination rates, confirmed cases, etc. Coupled with the importance of this information is understanding testing information: when to test, which test to use and how to interpret the results.
In this Virtual Grand Rounds, we will get an update from Erica Pan, M.D. on the status of COVID-19 in California. We will also hear from other experts on the role of testing at this phase of the pandemic, how the US differs from many countries in the availability and cost of rapid tests, and how investment from the federal government may improve our ability to test rapidly and frequently.
Featured Topics:
![]() |
|
Testing and COVID-19
|
 |
|
State of COVID-19 in California - Erica Pan, M.D., MPH, California State Epidemiologist and Deputy Director, California Department of Public Health, Center of Infectious Diseases |
 |
|
Injectable Monoclonal Antibodies: New options for the outpatient setting; Annie Leutkemeyer, M.D., Professor of Medicine, Zuckerberg San Francisco General Hospital and Trauma Center; Co-Chair, UC San Francisco Interventional Clinical Trials Committee;
Principal Investigator, COVID-19 Prevention Network. |
This event will be moderated by Kimberly Newell Green, M.D.
 |
|
Kimberly Newell Green, M.D., Immediate Past President, San Francisco Marin Medical Society; Associate Clinical Professor, University of California, San Francisco |
As a result of this activity, participants will be able to:
- Summarize the current epidemiology of COVID-19 in California
- Interpret vaccination progress in California, including pediatric vaccines and boosters.
- Summarize the status of COVID-10 tests available in the U.S.
- Discuss testing strategies with patients, including the accuracy of RT-PCR tests as compared with rapid antigen testing.
- Assess strategies and appropriate use of different COVID-19 tests for various purposes and in different settings.
Disclosure:
The following speakers disclose no relevant financial relationships with ineligible companies: Kimberly Newell Green, M.D.; Erica Pan, M.D., MPH
Annie Leutkemeyer, M.D., has identified a financial relationship and has received research grant support to UCSF for NIH sponsored studies from Astra Zenica, Merck, Gilead, Lilly and Novartis. These relationships have been mitigated through peer-review of presentation.
All other planners, staff and others involved with this activity have reported no relevant financial relationships with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
This activity has not received commercial support.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the California Medical Association (CMA) and California Health and Human Services Agency. CMA is accredited by ACCME to provide continuing medical education for physicians.
The California Medical Association designates this live activity for a maximum of 1.5 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
